View Clinical Trial (Medical Research Study)
Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
| City: |
|
Boston |
| State: |
|
Massachusetts |
| Zip Code: |
|
02115 |
| Conditions: |
|
Hypertension |
| Purpose: |
|
The purpose of this study is to develop an approach to provide personalized medicine to
individuals who have hypertension (high blood pressure). The investigators plan to use
people's genetic characteristics (traits) to determine what medication they should use to
lower their blood pressure most effectively. The investigators will give individuals one of
two medications to treat hypertension (lisinopril or atenolol). The investigators believe
that depending on the individuals genetic background one medication will work better in
lowering their blood pressure.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Male and female hypertensive participants who were previously studied in SCOR
program.
Exclusion Criteria:
- Diabetes
- Taking other medications beside thyroid or estrogen supplements.
|
| NCT ID: |
|
NCT01009944 |
| Primary Contact: |
|
Principal Investigator
Gordon H. Williams, MD
Brigham and Women's Hospital
Virginia Martinez
Phone: 617-278-0315
Email: vmartinez@partners.org
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Boston, Massachusetts 02115
United States
Virginia Martinez, BA
Phone: 617-278-0315
Email: vmartinez@partners.org
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|